Recent studies suggested that MASTL acts as an oncogenic kinase by inactivating tumor suppressive PP2A-B55 complex in breast cancer cells [11,12,13], thereby regulating various oncogenic properties, such as cellular transformation, chromosome instability, and metastasis [3,14,15]. The gene discussed is PTPA; the disease is breast carcinoma.